• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 通过调节肠道微生物群降低小鼠血浆三甲胺 N-氧化物水平。

Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota.

机构信息

The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

出版信息

Biomed Res Int. 2020 Oct 5;2020:9896743. doi: 10.1155/2020/9896743. eCollection 2020.

DOI:10.1155/2020/9896743
PMID:33083493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7558778/
Abstract

As a metabolite generated by gut microbiota, trimethylamine-N-oxide (TMAO) has been proven to promote atherosclerosis and is a novel potential risk factor for cardiovascular disease (CVD). The objective of this study was to examine whether regulating gut microbiota by vitamin D supplementation could reduce the plasma TMAO level in mice. For 16 weeks, C57BL/6J mice were fed a chow (C) or high-choline diet (HC) without or with supplementation of vitamin D (CD3 and HCD3) or a high-choline diet with vitamin D supplementation and antibiotics (HCD3A). The results indicate that the HC group exhibited higher plasma trimethylamine (TMA) and TMAO levels, lower richness of gut microbiota, and significantly increased Firmicutes and decreased Bacteroidetes as compared with group C. Vitamin D supplementation significantly reduced plasma TMA and TMAO levels in mice fed a high-choline diet. Furthermore, gut microbiota composition was regulated, and the Firmicutes/Bacteroidetes ratio was reduced by vitamin D. Spearman correlation analysis indicated that and were negatively correlated with plasma TMAO in the HC and HCD3 groups. Our study provides a novel avenue for the prevention and treatment of CVD with vitamin D.

摘要

作为肠道微生物群产生的一种代谢物,三甲胺 N-氧化物(TMAO)已被证明可促进动脉粥样硬化,是心血管疾病(CVD)的一种新的潜在危险因素。本研究旨在研究通过维生素 D 补充来调节肠道微生物群是否可以降低小鼠的血浆 TMAO 水平。在 16 周的时间里,C57BL/6J 小鼠分别喂食标准饮食(C)或高胆碱饮食(HC),或补充维生素 D(CD3 和 HCD3),或补充维生素 D 和抗生素的高胆碱饮食(HCD3A)。结果表明,与 C 组相比,HC 组的血浆三甲胺(TMA)和 TMAO 水平更高,肠道微生物群的丰富度更低,厚壁菌门显著增加,拟杆菌门减少。维生素 D 补充可显著降低高胆碱饮食喂养的小鼠的血浆 TMA 和 TMAO 水平。此外,维生素 D 还可调节肠道微生物群的组成,并降低 Firmicutes/Bacteroidetes 比值。Spearman 相关性分析表明,在 HC 和 HCD3 组中,和与血浆 TMAO 呈负相关。本研究为维生素 D 预防和治疗 CVD 提供了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/7954adfaf1e3/BMRI2020-9896743.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/d435907e80cc/BMRI2020-9896743.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/fb710c23446c/BMRI2020-9896743.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/bd5285d86ddb/BMRI2020-9896743.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/374937f582f1/BMRI2020-9896743.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/95904284a3a6/BMRI2020-9896743.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/7954adfaf1e3/BMRI2020-9896743.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/d435907e80cc/BMRI2020-9896743.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/fb710c23446c/BMRI2020-9896743.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/bd5285d86ddb/BMRI2020-9896743.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/374937f582f1/BMRI2020-9896743.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/95904284a3a6/BMRI2020-9896743.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acf/7558778/7954adfaf1e3/BMRI2020-9896743.006.jpg

相似文献

1
Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota.维生素 D 通过调节肠道微生物群降低小鼠血浆三甲胺 N-氧化物水平。
Biomed Res Int. 2020 Oct 5;2020:9896743. doi: 10.1155/2020/9896743. eCollection 2020.
2
Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.二甲双胍通过影响肠道微生物群落组成和功能缓解胆碱饮食诱导的 C57BL/6J 小鼠 TMAO 水平升高。
Nutr Diabetes. 2021 Jul 31;11(1):27. doi: 10.1038/s41387-021-00169-w.
3
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.肠道微生物群组成可调节饮食中胆碱的生物利用度以及促动脉粥样硬化代谢物氧化三甲胺的积累。
mBio. 2015 Mar 17;6(2):e02481. doi: 10.1128/mBio.02481-14.
4
Transmission of atherosclerosis susceptibility with gut microbial transplantation.通过肠道微生物移植传递动脉粥样硬化易感性。
J Biol Chem. 2015 Feb 27;290(9):5647-60. doi: 10.1074/jbc.M114.618249. Epub 2014 Dec 30.
5
Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e-/- Mice.产甲烷古菌肠道定植降低载脂蛋白 E 基因敲除小鼠血浆中的三甲基胺 N-氧化物浓度。
Sci Rep. 2018 Oct 3;8(1):14752. doi: 10.1038/s41598-018-33018-5.
6
and Attenuate Choline-Induced Plasma Trimethylamine N-Oxide Production by Modulating Gut Microbiota in Mice.并通过调节小鼠肠道微生物群来减弱胆碱诱导的血浆三甲胺 N-氧化物的产生。
Nutrients. 2022 Mar 14;14(6):1222. doi: 10.3390/nu14061222.
7
Dietary Methionine Restriction Alleviates Choline-Induced Tri-Methylamine-N-Oxide (TMAO) Elevation by Manipulating Gut Microbiota in Mice.饮食中蛋氨酸限制通过调控小鼠肠道微生物群减轻胆碱诱导的氧化三甲胺(TMAO)升高。
Nutrients. 2023 Jan 1;15(1):206. doi: 10.3390/nu15010206.
8
Choline and trimethylamine N-oxide supplementation in normal chow diet and western diet promotes the development of atherosclerosis in Apoe -/- mice through different mechanisms.胆碱和三甲胺 N-氧化物补充正常饲料饮食和西方饮食通过不同的机制促进 Apoe -/- 小鼠动脉粥样硬化的发展。
Int J Food Sci Nutr. 2023 Mar;74(2):234-246. doi: 10.1080/09637486.2023.2187742. Epub 2023 Apr 4.
9
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.小檗碱通过操纵肠道微生物组抑制三甲胺和氧化三甲胺的产生来减轻胆碱诱导的动脉粥样硬化。
NPJ Biofilms Microbiomes. 2021 Apr 16;7(1):36. doi: 10.1038/s41522-021-00205-8.
10
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.靶向抑制肠道微生物三甲胺 N-氧化物生成可减少慢性肾脏病小鼠模型的肾间质纤维化和功能障碍。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1239-1255. doi: 10.1161/ATVBAHA.120.314139. Epub 2020 Mar 26.

引用本文的文献

1
Novel opportunity of treatment for psycho-cardiologic disease by gut microbiome.肠道微生物群为心理心脏病学疾病提供的新型治疗机会。
Front Cardiovasc Med. 2025 Jul 22;12:1604962. doi: 10.3389/fcvm.2025.1604962. eCollection 2025.
2
Breaking the Cycle: Can Vitamin D Bridge the Gap Between Gut Microbiota and Immune Dynamics in Multiple Sclerosis?打破循环:维生素D能否弥合多发性硬化症中肠道微生物群与免疫动力学之间的差距?
Int J Mol Sci. 2025 Jun 7;26(12):5464. doi: 10.3390/ijms26125464.
3
Analysis of alterations in the composition of the intestinal microbiota in frail older individuals.

本文引用的文献

1
Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.植物乳杆菌 ZDY04 通过调节小鼠肠道微生物群表现出菌株特异性降低 TMAO 的特性。
Food Funct. 2018 Aug 15;9(8):4299-4309. doi: 10.1039/c8fo00349a.
2
Effects of Egg Consumption and Choline Supplementation on Plasma Choline and Trimethylamine-N-Oxide in a Young Population.鸡蛋摄入和胆碱补充对年轻人群血浆胆碱和氧化三甲胺的影响。
J Am Coll Nutr. 2018 Nov-Dec;37(8):716-723. doi: 10.1080/07315724.2018.1466213. Epub 2018 May 15.
3
Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
虚弱老年人肠道微生物群组成变化分析
PLoS One. 2025 May 8;20(5):e0320918. doi: 10.1371/journal.pone.0320918. eCollection 2025.
4
Advances in gut-lung axis research: clinical perspectives on pneumonia prevention and treatment.肠道-肺轴研究进展:肺炎防治的临床视角
Front Immunol. 2025 Apr 22;16:1576141. doi: 10.3389/fimmu.2025.1576141. eCollection 2025.
5
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential.肠-皮轴:一种具有治疗潜力的双向、微生物群驱动的关系。
Gut Microbes. 2025 Dec;17(1):2473524. doi: 10.1080/19490976.2025.2473524. Epub 2025 Mar 6.
6
Comparison of the role of vitamin D in normal organs and those affected by COVID-19.维生素D在正常器官与受新冠病毒感染的器官中所起作用的比较。
Int J Med Sci. 2025 Jan 1;22(2):240-251. doi: 10.7150/ijms.103260. eCollection 2025.
7
Topical Vitamin D Prevents Bone Loss and Inflammation in a Mouse Model.局部用维生素 D 可预防小鼠模型中的骨质流失和炎症。
J Dent Res. 2024 Aug;103(9):908-915. doi: 10.1177/00220345241259417. Epub 2024 Aug 5.
8
Research progress in the relationship between gut microbiota metabolite trimethylamine N-oxide and ischemic stroke.肠道微生物代谢产物三甲胺 N-氧化物与缺血性脑卒中关系的研究进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 28;49(3):447-456. doi: 10.11817/j.issn.1672-7347.2024.230427.
9
Gut microbiota bridges dietary nutrients and host immunity.肠道微生物群连接饮食营养和宿主免疫。
Sci China Life Sci. 2023 Nov;66(11):2466-2514. doi: 10.1007/s11427-023-2346-1. Epub 2023 Jun 5.
10
Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases.氧化三甲胺(TMAO)对慢性炎症和退行性疾病的影响
Biomedicines. 2023 Feb 2;11(2):431. doi: 10.3390/biomedicines11020431.
三甲基胺 N-氧化物:生活方式疾病中的有害、保护或诊断标志物?
Nutrition. 2018 Feb;46:7-12. doi: 10.1016/j.nut.2017.08.001. Epub 2017 Aug 7.
4
Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice.长期饮食添加神经鞘磷脂对小鼠动脉粥样硬化的影响。
PLoS One. 2017 Dec 14;12(12):e0189523. doi: 10.1371/journal.pone.0189523. eCollection 2017.
5
Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.大剂量每周补充维生素 D3 对囊性纤维化成人肠道和气道微生物群的影响:一项双盲、随机、安慰剂对照临床试验。
J Clin Endocrinol Metab. 2018 Feb 1;103(2):564-574. doi: 10.1210/jc.2017-01983.
6
Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.三甲胺 N-氧化物通过 CD36 依赖性 MAPK/JNK 通路促进动脉粥样硬化。
Biomed Pharmacother. 2018 Jan;97:941-947. doi: 10.1016/j.biopha.2017.11.016. Epub 2017 Nov 7.
7
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.肠道微生物生成的代谢产物三甲胺 N-氧化物作为心血管风险生物标志物:系统评价和剂量反应荟萃分析。
Eur Heart J. 2017 Oct 14;38(39):2948-2956. doi: 10.1093/eurheartj/ehx342.
8
Gut Microbiota and Atherosclerosis.肠道微生物群与动脉粥样硬化。
Curr Atheroscler Rep. 2017 Aug 25;19(10):39. doi: 10.1007/s11883-017-0675-9.
9
Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing.基于高通量测序技术的冠心病患者肠道菌群关联研究
Biomed Res Int. 2017;2017:3796359. doi: 10.1155/2017/3796359. Epub 2017 Apr 9.
10
Intestinal Immunity and Gut Microbiota in Atherogenesis.动脉粥样硬化发生中的肠道免疫与肠道微生物群
J Atheroscler Thromb. 2017 Feb 1;24(2):110-119. doi: 10.5551/jat.38265. Epub 2016 Dec 7.